000 01189 a2200313 4500
005 20250515085203.0
264 0 _c20070921
008 200709s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc071724
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiller, Nancy B
245 0 0 _aHuman papillomavirus vaccine.
_h[electronic resource]
260 _bThe New England journal of medicine
_cSep 2007
300 _a1154-5; author reply 1155-6 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAlphapapillomavirus
650 0 4 _aFemale
650 0 4 _aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
650 0 4 _aHumans
650 0 4 _aPapillomavirus Infections
_xprevention & control
650 0 4 _aPapillomavirus Vaccines
650 0 4 _aUterine Cervical Neoplasms
_xdiagnosis
650 0 4 _aUterine Cervical Dysplasia
_xprevention & control
700 1 _aRaychaudhuri, Gopa
700 1 _aToerner, Joseph G
773 0 _tThe New England journal of medicine
_gvol. 357
_gno. 11
_gp. 1154-5; author reply 1155-6
856 4 0 _uhttps://doi.org/10.1056/NEJMc071724
_zAvailable from publisher's website
999 _c17382980
_d17382980